|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$746,879
|
$522,816
|
Hickstein, Dennis
|
CCR (NCI)
|
|
Zebrafish Chemical and Classical Genetics Approach to the Pathogenesis of T-ALL
|
5K08CA133103-03
|
$140,940
|
$140,940
|
Gutierrez, Alejandro
|
DANA-FARBER CANCER INSTITUTE
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-31S1
|
$97,935
|
$979
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-32S1
|
$99,959
|
$1,000
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-32
|
$1,889,710
|
$18,897
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-13
|
$360,039
|
$32,404
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
VEGF blockade and alternative angiogenic pathways in neuroblastoma
|
3R01CA124644-03S1
|
$132,377
|
$132,377
|
YAMASHIRO, DARRELL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
VEGF blockade and alternative angiogenic pathways in neuroblastoma
|
5R01CA124644-03
|
$334,075
|
$334,075
|
YAMASHIRO, DARRELL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
VCU Minority-Based Community Clinical Oncology Program
|
2U10CA052784-20
|
$359,518
|
$3,595
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-20S1
|
$100,001
|
$1,000
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-20S2
|
$197,549
|
$1,975
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Vasculogenesis in Ewing's Sarcoma: Implications for Therapy
|
5R01CA103986-06
|
$254,023
|
$254,023
|
Kleinerman, Eugenie
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Vanderbilt Clinical Oncology Research Career Development Program
|
5K12CA090625-10
|
$293,882
|
$29,388
|
HANDE, KENNETH
|
VANDERBILT UNIVERSITY
|
|
Validating Syk as a Target for AML Therapy
|
5R01CA140292-02
|
$362,088
|
$362,088
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INSTITUTE
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-37S1
|
$101,020
|
$4,041
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-37S2
|
$148,912
|
$5,956
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-37
|
$4,795,480
|
$191,819
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-22
|
$2,399,682
|
$143,981
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Using mouse models to understand retinoblastoma initiation and progression
|
1R01CA148867-01A1
|
$161,850
|
$161,850
|
MacPherson, David
|
CARNEGIE INSTITUTION OF WASHINGTON, D.C.
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
ZIA BC 010871
|
$66,250
|
$19,875
|
Merlino, Glenn
|
CCR (NCI)
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S1
|
$99,949
|
$14,992
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S2
|
$73,975
|
$11,096
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S3
|
$98,980
|
$14,847
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-35
|
$6,464,088
|
$969,613
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S6
|
$1,444,105
|
$86,646
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S7
|
$98,815
|
$5,929
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
|
5P50CA100632-08
|
$2,158,273
|
$604,316
|
ISSA, JEAN-PIERRE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S1
|
$100,000
|
$3,000
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-23
|
$5,994,681
|
$179,840
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-15S1
|
$99,999
|
$5,000
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
University of California, Irvine Cancer Center Support Grant
|
5P30CA062203-15
|
$1,304,625
|
$65,231
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
1R01CA138744-01A1
|
$348,600
|
$348,600
|
BAKER, SHARYN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Tumor-produced TNF alpha as an inducer of immune resistance and tumor survival
|
1R01CA136663-01A2
|
$340,300
|
$340,300
|
Levitskaia, Elena
|
JOHNS HOPKINS UNIVERSITY
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$10,002
|
$10,002
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Tumor and Metastasis Therapy
|
ZIA BC 011024
|
$595,307
|
$595,307
|
Khanna, Chand
|
CCR (NCI)
|
|
Tumor and Metastasis Biology
|
ZIA BC 010566
|
$595,307
|
$595,307
|
Khanna, Chand
|
CCR (NCI)
|
|
Tryptophan Metabolism in Human Brain Tumors
|
5R01CA123451-03
|
$301,015
|
$60,203
|
JUHASZ, CSABA
|
WAYNE STATE UNIVERSITY
|
|
Trk Expression and Inhibition in Human Neuroblastomas
|
5R01CA094194-08
|
$387,333
|
$387,333
|
BRODEUR, GARRETT
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Trauma and Growth in Pediatric Cancer
|
1R01CA136782-01A2
|
$348,600
|
$348,600
|
Phipps, Sean
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Transposon-insertional Mutagenesis to Decipher Osteosarcomagenesis
|
5K08CA138764-02
|
$179,280
|
$179,280
|
Jones, Kevin
|
UNIVERSITY OF UTAH
|
|
Translational Genomics of MicroRNAs in Neuroblastoma
|
5K08CA136979-02
|
$158,005
|
$158,005
|
Cole, Kristina
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Transcriptional Regulation of Growth Related Genes
|
5R01CA045240-24
|
$275,365
|
$275,365
|
Farnham, PEGGY
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
Training of Physician Scientists in Cancer Research
|
2T32CA009659-16A2
|
$1
|
$1
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
TRAIL Therapy for Rhabdomyosacrcoma
|
5R01CA087952-09
|
$234,840
|
$234,840
|
HOUGHTON, JANET
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Towards a Mouse Model of Classical Hodgkin's Disease and PTLD
|
5R01CA098285-07
|
$494,023
|
$494,023
|
RAJEWSKY, KLAUS
|
IMMUNE DISEASE INSTITUTE, INC.
|
|
Toward Defining the Functional Methylome in Acute Lymphoblastic Leukemia
|
5K99CA132784-02
|
$115,638
|
$115,638
|
TAYLOR, KRISTEN
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
|
Tissue Array Research Program
|
ZIC BC 010923
|
$456,762
|
$22,838
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Therapeutic Targets in Alveolar Rhabdomyosarcoma
|
7R01CA133229-04
|
$145,134
|
$145,134
|
KELLER, CHARLES
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
|
Therapeutic Targets in Alveolar Rhabdomyosarcoma
|
5R01CA133229-03
|
$168,187
|
$168,187
|
KELLER, CHARLES
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
Therapeutic Index of Acute Lymphoblastic Leukemia
|
5P01CA068484-15
|
$3,395,115
|
$2,546,336
|
SALLAN, STEPHEN
|
DANA-FARBER CANCER INSTITUTE
|
Total relevant funding to Childhood Cancers for this search: $197,126,947
|